生物材料和再生医学的进展（Advances in biomaterials and regenerative medicine）.docVIP

下载本文档

2
0
约8.99千字
约 6页
2017-09-02 发布于河南
举报
版权申诉

生物材料和再生医学的进展（Advances in biomaterials and regenerative medicine）.doc

1、有哪些信誉好的足球投注网站（book118）网站文档一经付费（服务费），不意味着购买了该文档的版权，仅供个人/单位学习、研究之用，不得用于商业用途，未经授权，严禁复制、发行、汇编、翻译或者网络传播等，侵权必究。。
2、本站所有内容均由合作方或网友上传，本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺！文档内容仅供研究参考，付费前请自行鉴别。如您付费，意味着您自己接受本站规则且自行承担风险，本站不退款、不进行额外附加服务；查看《如何避免下载的几个坑》。如果您已付费下载过本站文档，您可以点击这里二次下载。
3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等，请点击“版权申诉”（推荐），也可以打举报电话：400-050-0827(电话支持时间：9:00-18:30)。
4、该文档为VIP文档，如果想要下载，成为VIP会员后，下载免费。
5、成为VIP后，下载本文档将扣除1次下载权益。下载后，不支持退款、换文档。如有疑问请联系我们。
6、成为VIP后，您将拥有八大权益，权益包括：VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
7、VIP文档为合作方或网友上传，每下载1次，网站将根据用户上传文档的质量评分、类型等，对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档

生物材料和再生医学的进展（Advances in biomaterials and regenerative medicine）

生物材料和再生医学的进展（Advances in biomaterials and regenerative medicine） Materials, also called biomedical materials, refer to the materials used for diagnosis, treatment, repair or replacement of human tissues and organs or for the purpose of medical treatment. [1]. Biological materials originally used in the clinic are entirely derived from existing substances in nature. However, with the increasing understanding of the immune system, most of these materials have been proved to be pathogenic or toxic to humans. Century 60~70, in the industrialization of biocompatibility on the basis of the research, developed the first generation of biological materials and products in clinical applications, such as in vivo bone nail and bone plate, artificial joint, artificial heart valves, artificial blood vessel, artificial crystal and artificial kidney. Since the century since 80s, the quality of life has made rapid development for the purpose of biological material for medical and health care and promotion, respectively, by more than 40 kinds of different materials (implant prosthesis), there have been more than 50 implant devices have been used in clinical. These biological materials have a common property: biological inertness. The principle of biomaterials development is to minimize the response of receptors to foreign bodies in implantable devices. This principle lasted for more than 20 years. During this time, tens of millions of patients were implanted with inert materials, and their quality of life improved significantly over the course of the year after implantation. The first generation of biological materials prepared by the various instruments are still in clinical use, the worlds annual sales of more than billion. Starting from the second generation of biological materials, the focus of the biomaterial field gradually shifted from biological inertness to biological activity. This active material can undergo controlled reactions under physiological conditions and act on th